Clinical trial Recruiting at 1 site Interventional Ages 25 to 69

Patient navigation program for cervical cancer screening in Senegal

Official title: Adaptation and Implementation of a Patient Navigation Program for Cervical Cancer Screening Across Contexts in Senegal

Run by University of Illinois Chicago · NCT05544084 · Data updated 2026-11-12

This study is testing a new support program to help women in Senegal get screened for cervical cancer and access treatment more easily.

Quick facts

Study typeInterventional
Ages25 Years to 69 Years
SexAll
Enrollment901 (estimated)
SponsorUniversity of Illinois Chicago
Academic / other
Locations1 site (Dakar)
StatusRecruiting
StartedAugust 1, 2023
Main results expectedMarch 30, 2027
Study endsAugust 28, 2027
Registry record updatedMay 8, 2026
Trial IDNCT05544084 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include Senegalese citizens aged 25 to 69 who are willing to participate in survey assessments and seek cervical cancer prevention services.

Probably not a fit

Patients who are not citizens of Senegal or those outside the specified age range may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to prevent cervical cancer deaths in Senegal by addressing barriers to screening and treatment among women. Using a mixed methods approach, the study will adapt an evidence-based patient navigation program to fit both urban and rural contexts in Senegal. The Dynamic Adaptation Process will be employed to evaluate the program's effectiveness and implementation outcomes. The study will involve a stepped-wedge randomized pragmatic trial to assess the impact of navigation services on screening rates and treatment access.

Why it matters

Potential benefit: If successful, this program could significantly increase cervical cancer screening rates and improve treatment access for women in Senegal.

How similar studies have gone: Other studies have shown success with patient navigation programs in improving cancer screening rates, indicating a promising approach for this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

The inclusion criteria for samples a, b, \& c are as follows:

1\) Senegal citizen between the ages of 25 and 69, 2) willing to participate in survey assessments;

The additional criteria apply for both women and men for the follow samples:

Sample a: 3) an invited member of the study National Advisory Board or Regional Implementation Resource Teams as defined above; 4) able to read and write in French.

Sample b: 3) employed by the state at a study site health facility as a patient navigator, clinician (nurse, midwife) who treats and educates patients, or is a community health worker at the facility or community level (Bajenu Gox - women's health educator).

Sample c: Women: 3) a woman living with a male partner who also agrees to participate in the study, 4) eligible to seek cervical cancer prevention services at a designated health facility in Senegal. Men: 3) a man living in a household with at least one woman eligible to seek cervical cancer prevention services at a designated health facility in Senegal.

Exclusion Criteria:

* No additional exclusion criteria exist.

Where it's running

  • University of Cheikh Anta Diop, Institute of Health and Development
    Dakar, Senegal
    Recruiting

Study contacts

  • Principal investigator: Jon A Dykens, MD, MPH — University of Illinois Chicago
  • Study coordinator: Jon A Dykens, MD, MPH
  • Email: jdykens@uic.edu
  • Phone: 573-355-0452

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.